Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Diversification is crucial for investment success. It helps mitigate risks and can lead to better returns in the long run.
27,279 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
A widening Epstein-related inquiry fuels renewed scrutiny of global power players. As whispers of the former Prince A...
A coordinated crackdown on outlaw motorcycle clubs is reshaping risk pricing in niche markets. Here’s how investors s...
U.S. stocks rebound Tuesday after Monday’s tariff-driven drop, with the S&P 500 and Dow clawing back losses as invest...
Cava posted a record year, topping rivals with 2025 revenue of $1.169 billion and 72 new restaurants. The chain signa...
Mullen’s share path remains highly uncertain as the EV market shifts and capital needs loom. This report maps potenti...
Ripple is channeling billions into infrastructure to connect traditional finance with blockchain systems, reshaping t...
Bitcoin slips below key levels as geopolitical tensions flare, sparking a broad crypto retreat. Traders weigh risk an...
European markets tumbled on Monday as new Middle East tensions joined the AI scare trade, pushing oil higher and risk...
Budget models warn that trump’s strikes iran could carry a heavy price tag for taxpayers and households, with direct ...
Solana SOL bounced back above a critical level as Bitcoin steadies, reviving a solana price prediction: just debate a...
Canaccord Genuity lowers AeroVironment's target to $330 but preserves a Buy rating, underscoring long-term optimism a...